Government on Friday rejected suggestions that the five-month ban Swiss giant Nestle’s Maggi noodles was in retaliation to EU’s clampdown on marketing of 700 generic drugs for alleged manipulation of clinical trials by GVK Bio.
“I don’t think that these two issues are at all linked. Many countries take many decisions in what they deem to be appropriate regulatory steps to protect their population,” Department of Commerce Secretary Rita Teaotia told reporters on the sidelines of a programme at the Indian School of Business (ISB) here.